Search for a command to run...
Welcure Drugs & Pharmaceuticals Ltd. stands out as a significant underperformer in its sector, characterized by negative growth metrics, no profitability, and an excessively high PEG ratio. In contrast, peers like Redington Ltd. demonstrate strong profitability and growth, making them more attractive overall.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Welcure Drugs & Pharmaceuticals Ltd. | ₹9.25 | ₹103.93Cr | 47.88 | -34.66% | -2.97 |
ADANIENT | ₹2,283.00 | ₹2,63,499.29Cr | 43.53 | 11.81% | 1.45 |
REDINGTON | ₹243.85 | ₹19,063.56Cr | 13.20 | 23.63% | 0.37 |
CPPLUS | ₹1,246.40 | ₹14,610.54Cr | 107.99 | 41.16% | 0.46 |
CELLO | ₹535.15 | ₹11,820.66Cr | 120.15 | 43.92% | 0.32 |
HONASA | ₹298.95 | ₹9,721.38Cr | 151.70 | 8.99% | - |
MMTC | ₹62.18 | ₹9,327.00Cr | 134.15 | 6.90% | - |